First Time Loading...

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.82 CNY 1.73% Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 34.18 CNY with a low forecast of 30.3 CNY and a high forecast of 40.95 CNY.

Lowest
Price Target
30.3 CNY
5% Downside
Average
Price Target
34.18 CNY
7% Upside
Highest
Price Target
40.95 CNY
29% Upside
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors:
Price Targets
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
8% Upside
MGNX
MacroGenics Inc
73% Upside
MRUS
Merus NV
38% Upside
300896
Imeik Technology Development Co Ltd
136% Upside
VCEL
Vericel Corp
20% Upside
005690
Pharmicell Co Ltd
201% Upside
PROB
Probi AB
55% Upside
XOMA
XOMA Corp
185% Upside

Revenue
Forecast

Revenue Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -4%.

22%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 12%.

17%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
China Resources Boya Bio pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 41%.

6%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's stock price target?
Price Target
34.18 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 34.18 CNY with a low forecast of 30.3 CNY and a high forecast of 40.95 CNY.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -4%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 12%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 41%.